These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31611941)

  • 1. Role of bile acids in the diagnosis and progression of liver cirrhosis: A prospective observational study.
    Liu N; Feng J; Lv Y; Liu Q; Deng J; Xia Y; Guo C; Zhou Y
    Exp Ther Med; 2019 Nov; 18(5):4058-4066. PubMed ID: 31611941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.
    Horvatits T; Drolz A; Roedl K; Rutter K; Ferlitsch A; Fauler G; Trauner M; Fuhrmann V
    Liver Int; 2017 Feb; 37(2):224-231. PubMed ID: 27416294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of Bile Acids in Diagnosing Hepatitis C Virus-Induced Liver Cirrhosis and Hepatocellular Carcinoma.
    Khalil A; ElSheashaey A; Abdelsameea E; Obada M; Bayomy F F M; El-Said H
    Br J Biomed Sci; 2022; 79():10191. PubMed ID: 35996509
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased levels of typically fetal bile acid species in patients with hepatocellular carcinoma.
    El-Mir MY; Badia MD; Luengo N; Monte MJ; Marin JJ
    Clin Sci (Lond); 2001 May; 100(5):499-508. PubMed ID: 11294690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered bile acid glycine : taurine ratio in the progression of chronic liver disease.
    Chen T; Zhou K; Sun T; Sang C; Jia W; Xie G
    J Gastroenterol Hepatol; 2022 Jan; 37(1):208-215. PubMed ID: 34655465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents.
    Luo L; Schomaker S; Houle C; Aubrecht J; Colangelo JL
    Toxicol Sci; 2014 Jan; 137(1):12-25. PubMed ID: 24085190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
    Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
    Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.
    Wang X; Xie G; Zhao A; Zheng X; Huang F; Wang Y; Yao C; Jia W; Liu P
    J Proteome Res; 2016 Apr; 15(4):1126-34. PubMed ID: 25964117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats.
    Slopianka M; Herrmann A; Pavkovic M; Ellinger-Ziegelbauer H; Ernst R; Mally A; Keck M; Riefke B
    Toxicology; 2017 Jul; 386():1-10. PubMed ID: 28529062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugated bile acids in gallbladder bile and serum as potential biomarkers for cholesterol polyps and adenomatous polyps.
    Zhao MF; Huang P; Ge CL; Sun T; Ma ZG; Ye FF
    Int J Biol Markers; 2016 Feb; 31(1):e73-9. PubMed ID: 26541419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for biomarkers of liver injury induced by Polygonum multiflorum: a targeted metabolomic study.
    Dong Q; Li N; Li Q; Zhang CE; Feng WW; Li GQ; Li RY; Tu C; Han X; Bai ZF; Zhang YM; Niu M; Ma ZJ; Xiao XH; Wang JB
    Front Pharmacol; 2015; 6():217. PubMed ID: 26483689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease.
    Sang C; Wang X; Zhou K; Sun T; Bian H; Gao X; Wang Y; Zhang H; Jia W; Liu P; Xie G; Chen T
    J Proteome Res; 2021 May; 20(5):2340-2351. PubMed ID: 33754726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancer.
    Farhat Z; Freedman ND; Sampson JN; Falk RT; Koshiol J; Weinstein SJ; Albanes D; Sinha R; Loftfield E
    Hepatol Commun; 2022 Sep; 6(9):2391-2399. PubMed ID: 35678016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of individual serum bile acids in chronic liver diseases: fasting levels and results of oral chenodeoxycholic acid tolerance test.
    Adachi Y; Nanno T; Itoh T; Kurumi Y; Yamazaki K; Sawada Y; Yamamoto T
    Gastroenterol Jpn; 1988 Aug; 23(4):401-7. PubMed ID: 3181666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments.
    Liu Z; Zhang Z; Huang M; Sun X; Liu B; Guo Q; Chang Q; Duan Z
    BMC Gastroenterol; 2018 Jul; 18(1):112. PubMed ID: 29996772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of serum bile acids as metabolite biomarkers for liver cirrhosis: a systematic review and meta-analysis.
    Han X; Wang J; Gu H; Guo H; Cai Y; Liao X; Jiang M
    Metabolomics; 2022 Jun; 18(7):43. PubMed ID: 35759044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study.
    Lu J; Wang S; Li M; Gao Z; Xu Y; Zhao X; Hu C; Zhang Y; Liu R; Hu R; Shi L; Zheng R; Du R; Su Q; Wang J; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Wang X; Li Q; Qin G; Wan Q; Chen G; Xu M; Dai M; Zhang D; Tang X; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Mu Y; Chen L; Zhao J; Xu G; Ning G; Bi Y; Wang W;
    Diabetes Care; 2021 Feb; 44(2):499-510. PubMed ID: 33355246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study.
    Mustika S; Wijaya H; Pratomo B
    Acta Med Indones; 2019 Apr; 51(2):137-144. PubMed ID: 31383828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
    Puri P; Daita K; Joyce A; Mirshahi F; Santhekadur PK; Cazanave S; Luketic VA; Siddiqui MS; Boyett S; Min HK; Kumar DP; Kohli R; Zhou H; Hylemon PB; Contos MJ; Idowu M; Sanyal AJ
    Hepatology; 2018 Feb; 67(2):534-548. PubMed ID: 28696585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.